Cell Source, Inc. (CLCS) [Rocket]

Overview

Cell Source, Inc. (CLCS)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
10/06/2023	D	Form D - Notice of Exempt Offering of Securities:
08/23/2023	10-Q	Quarterly Report for the period ended March 31, 2023
08/15/2023	NT 10-Q	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
05/16/2023	NT 10-Q	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
03/31/2023	NT 10-K	Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
12/08/2022	10-Q	Quarterly Report for the period ended September 30, 2022
12/02/2022	10-Q	Quarterly Report for the period ended June 30, 2022

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
Revenues	0.0	0.0	0.0	0.0	-0.2	-0.2	0.0	0.0
Revenue growth				-100.0%	-28.1%	646.4%	4738.6%	-99.9%
Cost of goods sold	0.0	0.0	0.0	0.0	-4.6	-4.6	-4.6	-8.1
Gross profit	0.0	0.0	0.0	0.0	4.4	4.4	4.6	8.1
Gross margin					-2520.8%	-1805.0%	-14130.8%	-1202886.9%
Selling, general and administrative					0.8	1.0	1.1	2.2
Research and development	1.3	0.8	2.5	0.3	0.6	0.6	0.4	0.8
General and administrative	2.7	2.6	1.3	1.3
EBIT	-4.0	-3.6	-3.9	-2.0	-3.7	0.3	-2.2	-4.1
EBIT margin					2089.6%	-112.4%	6624.7%	601493.5%
Pre-tax income	-5.5	-4.6	-4.5	-2.1	-3.3	-1.0	-2.5	-4.1
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-6.4	-5.4	-5.2	-2.6	-3.1	-1.0	-2.5	-4.1
Net margin					1761.7%	397.6%	7678.5%	601999.9%

Diluted EPS	($0.19)	($0.19)	($0.18)	($0.09)	($0.09)	($0.09)	($0.09)	($0.18)
Shares outstanding (diluted)	33.1	29.1	28.3	27.5	26.8	26.2	25.7	22.2

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.